{"title":"HIV药物管道有望提供更多固定剂量组合。到2011年，医疗服务提供者和患者可能能够在几种“一粒，一天一次”的方案中进行选择。","authors":"H. Albrecht","doi":"10.1056/AC201001040000010","DOIUrl":null,"url":null,"abstract":"Based on pure numbers, the current pipeline for HIV drug development appears reasonably robust, with at least a dozen agents in phase II or III","PeriodicalId":88277,"journal":{"name":"Journal watch. AIDS clinical care","volume":"76 1","pages":"6"},"PeriodicalIF":0.0000,"publicationDate":"2010-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"HIV drug pipeline promises more fixed-dose combinations. By 2011, providers and patients may be able to choose between several \\\"one pill, once-daily\\\" options.\",\"authors\":\"H. Albrecht\",\"doi\":\"10.1056/AC201001040000010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Based on pure numbers, the current pipeline for HIV drug development appears reasonably robust, with at least a dozen agents in phase II or III\",\"PeriodicalId\":88277,\"journal\":{\"name\":\"Journal watch. AIDS clinical care\",\"volume\":\"76 1\",\"pages\":\"6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-01-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal watch. AIDS clinical care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1056/AC201001040000010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal watch. AIDS clinical care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1056/AC201001040000010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
HIV drug pipeline promises more fixed-dose combinations. By 2011, providers and patients may be able to choose between several "one pill, once-daily" options.
Based on pure numbers, the current pipeline for HIV drug development appears reasonably robust, with at least a dozen agents in phase II or III
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
